Dr. Daud Discusses the Current Status of Immunotherapy in Melanoma

Adil Daud, MD, clinical professor, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, at University of California, San Francisco, discusses the current status of immunotherapy in melanoma.

Adil Daud, MD, clinical professor, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, at University of California, San Francisco, discusses the current status of immunotherapy in melanoma.

Immunotherapy is at a very exciting point in melanoma, says Daud. Specifically, there were a number of combinations presented at the 2017 ASCO Annual Meeting for the relapse/refractory population that showed responses.

Related Content:

UCSF Helen Diller Family Comprehensive Cancer CenterOncLive TVImmunotherapy in MelanomaMelanoma & Skin CancerImmuno-Oncology
Dr Tarantino on the Safety of T-DXd and T-DM1 in HER2+ Breast Cancer
Dr Davis on the Potential For ADCs to Continue to Reshape Breast Cancer Treatment
Dr Khushalani on Fixed-Dose Treatment Regimens in Advanced Melanoma